Literature DB >> 28411909

Current Trends in Renal Surgery and Observation for Small Renal Masses.

Siri Drangsholt1, William C Huang2.   

Abstract

There has been a rising incidence of small renal masses and concomitant downward stage migration. This has led to an evolution in the management of kidney cancer from radical nephrectomy to nephron-sparing treatment options including observation. The adoption of partial nephrectomy continues to increase but is still incomplete leading to significant disparities in the delivery of care throughout the country. Surgical excision remains the treatment of choice for small kidney cancers; however, ablative therapies and active surveillance are emerging as reasonable options for select patients. With continued refinements in treatment options and improvements in ability to risk stratify SRMs, the current treatment trends will likely continue to evolve.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Kidney cancer; Observation; Surgery; Treatment trends

Mesh:

Year:  2017        PMID: 28411909     DOI: 10.1016/j.ucl.2016.12.003

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  5 in total

Review 1.  Treatment approaches to small renal masses in patients of advanced age (≥75 years).

Authors:  Muhammet Fuat Özcan; Serkan Altınova; Ali Atan
Journal:  Turk J Urol       Date:  2018-07

2.  Tumor location does not limit percutaneous treatment of small renal masses with microwave ablation.

Authors:  Xiaosong Meng; Rashed Ghandour; Vitaly Margulis
Journal:  Ann Transl Med       Date:  2019-09

3.  Attitude towards active surveillance: a cross-sectional survey among patients with uroandrological disorders.

Authors:  Paolo Capogrosso; Luca Boeri; Eugenio Ventimiglia; Ilenya Camozzi; Walter Cazzaniga; Francesco Chierigo; Roberta Scano; Alberto Briganti; Francesco Montorsi; Andrea Salonia
Journal:  BMJ Open       Date:  2018-08-29       Impact factor: 2.692

4.  Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma.

Authors:  Qian Zhu; Ai-Lin Zhong; Hao Hu; Jing-Jing Zhao; De-Sheng Weng; Yan Tang; Qiu-Zhong Pan; Zi-Qi Zhou; Meng-Jia Song; Jie-Ying Yang; Jun-Yi He; Yuan Liu; Min Li; Wan-Ming Hu; Chao-Pin Yang; Tong Xiang; Ming-Yuan Chen; Gang Ma; Ling Guo; Jian-Chuan Xia
Journal:  J Hematol Oncol       Date:  2020-01-03       Impact factor: 17.388

5.  circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis.

Authors:  Huan Liu; Guanghui Hu; Zaoyu Wang; Qunlong Liu; Jin Zhang; Yonghui Chen; Yiran Huang; Wei Xue; Yunfei Xu; Wei Zhai
Journal:  Theranostics       Date:  2020-08-29       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.